If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Omeros ( OMER ) stock surged sharply today, after the company announced the FDA approval of its drug candidate narsoplimab in the indication of hematopoietic stem cell transplant-associated thrombotic microangiopat ...